Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Mar 7, 2020
Emerging Company Profile

Kira: depleting activated dendritic cells

Kira aims to deplete activated dendritic cells for GvHD and autoimmune disease
BioCentury | Mar 29, 2019
Targets & Mechanisms

Next-wave targets at AACR 2019 start filling the blanks in the tumor microenvironment

A look at new and emerging targets at AACR 2019 and their mechanisms
BioCentury | Nov 30, 2018
Targets & Mechanisms

Adhesion targets emerge at ASH 2018

Emerging science on adhesion molecules, RNA-binding proteins and more at ASH 2018
BioCentury | Aug 19, 2013
Clinical News

Argos, Danaher preclinical data

BioCentury | May 16, 2011
Clinical News

Argos, Beckman Coulter preclinical data

BioCentury | Apr 30, 2009
Distillery Therapeutics

Indication: Renal disease

BioCentury | Mar 16, 2009
Clinical News

Argos, Beckman Coulter preclinical data

BioCentury | Feb 19, 2009
Cover Story

Dendritic cell depletion for acute GvHD

BioCentury | Feb 12, 2009
Distillery Therapeutics

Indication: Transplantation

BioCentury | Aug 7, 2008
Targets & Mechanisms

Avoiding TB's subversion

Items per page:
1 - 10 of 14